MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Gastroenterology_Gastrointestinal (to include Liver, Pancreas & metabolic dysfunction-associated steatotic liver disease (MASLD), Gout, MASH (Metabolic dysfunction-associated steatohepatitis), formerly, NASH (Non-Alcoholic SteatoHepatitis)Non-Alcoholic SteatoHepatitis (NASH)
Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD)*
Organization & Developments: Galmed
Parents
Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD)*
Children
2016: Biotech Forum Daily Digest: Tesaro's Huge Week! Brexit Losses Gone, Spotlight On Applied Genetics Technologies
2018: Galmed Surges 151% After Positive Mid-Stage NASH Results - Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD)
2018: Galmed Tumbles On Phase 2 NASH Data, But There Is More To The Story Than Meets The Eye - Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD)
2018: Galmed_Buy This Small Cap NASH Play?seekingalpha.com
2018: NASH Epidemiology: Growing Prevalence And A Look At Galmed_seekingalpha.com
2023: Galmed Touts Strong Phase III NASH Data for Aramchol
Jumps
*Key People: Galmed
Finance & Acquisitions: Galmed